BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• Drug Development

  Ligand Pharmaceuticals Inc. Announces Positive Preclinical Data on Small Molecule Erythropoietin Receptor Agonists

  December 6, 2010

   · 

  1 min read
• BioMidwest

  Allos Therapeutics, Inc. Reports New Analyses of FOLOTYN(R) Data from PROPEL Trial in Relapsed or Refractory Peripheral T-Cell Lymphoma

  December 6, 2010

   · 

  1 min read
• Drug Development

  Ariad Pharmaceuticals, Inc.'s Ponatinib Shows Clinical Evidence of Improving Anti-Leukemic Activity in Patients with Drug-Resistant CML

  December 6, 2010

   · 

  1 min read
• Drug Development

  Celgene International Sárl Release: New Clinical Data Evaluating ISTODAX(R) in Pivotal Open-Label Phase II Study for Patients with Peripheral T-Cell Lymphoma (PTCL)

  December 6, 2010

   · 

  1 min read
• Business

  Merrion Pharmaceuticals, Inc. Signs Feasibility and Option Agreement for 3 Drugs With International ‘Top Ten’ Pharmaceutical Company

  December 6, 2010

   · 

  1 min read
• Drug Development

  Geron Corporation Presents Clinical Data on Its Telomerase Vaccine at the 2010 American Society of Hematology Meeting

  December 6, 2010

   · 

  1 min read
• Drug Development

  Baxter International, Inc. Presents Interim Phase 1 Safety and Tolerability Data at American Society of Hematology Meeting for Its Investigational Treatment for von Willebrand Disease

  December 6, 2010

   · 

  1 min read
• Biotech Bay

  ChemGenex Pharmaceuticals Limited Presents Updated Analysis at American Society of Hematology on OMAPRO(TM) in CML Patients Who Failed Two or Three Approved TKI Drugs

  December 6, 2010

   · 

  1 min read
• BioCapital

  iBio, Inc. Release: Another Clinical Trial Commenced for a Product Based on iBioLaunch Technology

  December 6, 2010

   · 

  1 min read
• Business

  MabCure, Inc. Welcomes Dr. Charles T. Tackney as New Chief Scientific Officer

  December 6, 2010

   · 

  2 min read